WHAT WE DO
Seagrove Partners delivers strategic intelligence across healthcare — syndicated, custom, and on demand. Every engagement is grounded in curated clinician access, proprietary data assets, and analysis built by operators who have sat in our clients' seats.
01 · Syndicated Research
The foundation of the Seagrove platform is a syndicated intelligence portfolio that diabetes and oncology clients rely on year-round. In diabetes, membership includes the GlobeVIEW forecasting workbook covering device and drug markets across 52 geographies, the SeaTRAK quarterly competitive tracker, and five primary research waves each year spanning prescribers, patients, payers, and international clinicians. In oncology, GlobeVIEW Oncology Select pairs quarterly competitive tracking with client-selected custom deep dives, so members direct the depth where they need it most. Syndicated membership delivers institutional-grade intelligence at a fraction of the cost of commissioning it alone.
02 · Pulse — Custom Research Across Eight Verticals
When the question is yours alone, Pulse is Seagrove's custom research engine, available across all eight of our verticals. Each engagement is designed from scratch: quantitative surveys, qualitative interviews, and hybrid designs fielded to curated panels of physicians, nurse practitioners, physician assistants, and other clinical decision-makers across 49 states. Seagrove handles the full arc — study design, instrument development, fielding, analysis, and a boardroom-ready deliverable — and because our panels are standing and curated rather than assembled ad hoc, projects move from kickoff to findings in weeks, not quarters. Engagements scale from rapid single-question studies to multi-wave strategic programs.
03 · Amulet24 — On-Demand Intelligence, Within 24 Hours
Some questions can't wait for a fielded study. Amulet24 is an annual intelligence membership built for exactly those moments: members submit a question — a competitor's announcement, a surprising data readout, a payer policy shift — and receive an initial Seagrove response within 24 hours, followed by deeper analysis as the situation develops. Responses draw on our curated clinician panels, our syndicated data assets, and a decade of category expertise, so answers arrive with context rather than caveats. Amulet24 grew out of AMULET, our long-running client inquiry and white paper service, and extends it into an always-on resource.
04 · Focus Groups & Qualitative Research
Numbers tell you what is happening; conversation tells you why. Seagrove designs and moderates focus groups, in-depth interviews, and advisory boards with prescribers, patients, and payers, conducted virtually or in person. We handle every stage — recruiting from our curated clinical panels, discussion guide development, professional moderation, and synthesis that turns raw discussion into decision-ready themes. Qualitative work is frequently paired with our quantitative waves, using groups to pressure-test messaging, explore adoption barriers, or add texture to survey findings, and clients can observe sessions live and receive full transcripts alongside the summary report.
05 · Competitive Intelligence & Conference Coverage
Markets move quarterly, and our tracking does too. SeaTRAK, Seagrove's competitive intelligence tracker, monitors every major player each quarter with standardized company profiles covering financial results and strategic positioning, plus earnings-season client notes that go deep on the quarters that matter. We supplement the tracker with on-the-ground coverage of the major scientific meetings, distilling sessions into rapid, decision-focused summaries, and with continuous monitoring of launches, pipelines, and regulatory milestones. The goal is simple: clients should never be surprised by a competitor move, and when one happens, they should already understand what it means.
06 · Forecasting & Market Modeling
Forecasting sits at the core of the Seagrove platform. The GlobeVIEW workbook models device and drug markets across 52 geographies, with patient-level builds, competitive share scenarios, and assumptions clients can interrogate line by line rather than accept on faith. Beyond the flagship model, we build custom forecasts and market models to order: uptake curves for a launch, WAC-to-net pricing and cost models, scenario analyses for coverage and reimbursement changes, and addressable-market sizing for new categories. Every model is delivered as a living tool that clients can own, stress-test, and update — not a static PDF.
07 · Strategic Advisory & Investor Diligence
Beyond structured research, clients engage Seagrove as a thinking partner. Our AMULET white papers deliver rigorous, source-backed analysis of a single strategic question — a pricing decision, an emerging competitor, a market-entry choice — typically within days. For investors, we support diligence with syndicated data access, expert perspective, and rapid channel checks grounded in our clinician panels. For commercial teams, we advise on launch strategy, positioning, and market development, informed by operator experience that includes leading commercial analytics through one of the device industry's landmark launches. Seagrove Partners is a certified California Small Business Enterprise.